Aims To examine adherence to the hospital DKA/HHS insulin infusion protocol, assess outcomes in patients admitted with DKA or HHS, and determine if improvements have been observed from a similar audit in 2016. Methods An audit was conducted on 40 patients admitted to Shellharbour Hospital with ...
The six-hourly subcutaneous regular insulin use was found to be safe and effective alternative to slow IV insulin infusion for the treatment of DKA in a non PICU setting. As it resulted in minimum morbidity and no mortality, we recommend its use in the treatment of DKA irrespective of its ...
OBJECTIVE—The purpose of this study was to assess the efficacy of an insulin priming dose with a continuous insulin infusion versus two continuous infusions without a priming dose. RESEARCH DESIGN AND METHODS—This prospective randomized protocol used three insulin therapy methods: 1) load group usi...
Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol 2018, Diabetes Technology and Therapeutics Carbohydrate counting in children and adolescents with type 1 diabetes 2018, Nutrients Use and Effectiveness of Continuous Subcutaneous...
Ambulatory Patients (Outpatient Services) in East Africa In East Africa, ambulatory patients receive a less intensive treatment protocol for hyperglycemia with delayed insulin treatment because of multiple barriers that include availability of insulin and associated delivery devices; patients’ fear regarding...
Results: Ninety patients were prospectively identified for inclusion in the study. Fourteen patients were excluded; 10 who did not have diabetes or inpatient hyperglycemia, 2 were not managed by IMS, 2 had DKA. Seventy patients met inclusion criteria: 61% female, mean age (SD) 64.8 (12.8) ...
Patient was admitted to the ICU with an insulin drip following our hospital's DKA protocol. After admission, she became hypotensive with increase work of breathing, for which she was intubated and started on vasopressin. On the second day of admission, Endocrinology was consulted due to inability...
DKA—begin 0.1U/kg IV bolus of R, then 0.1U/kg/h infusion; decrease infusion rate when glucose <275mg/dl • Contraindications—hypersensitivity to drug or class, hypoglycemia, IV administration (N, L, U) • Caution—hypokalemia, renal or hepatic dysfunction, thyroid disorder ...
Insulin pump therapy has been around since the late 1970s. From the “Big Blue Brick” to the sensor augmented pumps, significant improvements have been made in the technology. The first hybrid close loop device was approved for clinical use by the FDA i
glulisineinsulinin100ccNS(1unitinsulin/cc)(Circleone)4)Giv ini ialinsulinbolus:u BolusunitsofI.V.insulin=Glucose÷100(e.g.ifglucose=240mg/dL,give2.5units)5)S ar insulininfusion:u Initialinfusionrateofinsulinunits/h=Glucose÷100(e.g.ifglucose=240,begin2.5units/h)6)targ rang forglucos :...